Committee for Advanced Therapies (CAT) and the German Society for Transfusion Medicine and Immunohaematology (DGTI) workshop on advanced-therapy medicinal products: How to bring cell-based medicinal products successfully to the market

  • Email
  • Help

Details

TitleCommittee for Advanced Therapies (CAT) and the German Society for Transfusion Medicine and Immunohaematology (DGTI) workshop on advanced-therapy medicinal products: How to bring cell-based medicinal products successfully to the market
Date11/09/2014 - 11/09/2014
LocationDresden, Germany
SummaryThe workshop is co-organised by the European Medicines Agency's (EMA's) Committee for Advanced Therapies (CAT) and the German Society for Transfusion Medicine and Immunohaematology (DGTI) in collaboration with the German Stem Cell Network (GSCN) and aims to strengthen dialogue between CAT and the advanced-therapy-medicinal-product (ATMP) developers in industry, academia and hospitals and to facilitate ATMP development and access to the registration procedure. The workshop will allow for the attendees to learn about the development and authorisation of cell-based ATMPs in the European Union and the role of the CAT; to learn about the support provided by EMA and the CAT to ATMP developers; to understand the criteria that CAT applies for the classification of ATMPs; and to hear about CAT’s considerations and recent interactions with experts on cell-based therapies for cardiac repair. It will also allow to interact directly with the Regulators in an open forum discussion.

All documents

Name Language First published Last updated
Workshop programme - Committee for Advanced Therapies (CAT) and the German Society for Transfusion Medicine and Immunohaematology (DGTI) workshop on advanced-therapy medicinal products: How to bring cell-based medicinal products successfully to the market (English only) 2014-06-26  
Invitation - Committee for Advanced Therapies (CAT) and the German Society for Transfusion Medicine and Immunohaematology (DGTI) workshop on advanced-therapy medicinal products: How to bring cell-based medicinal products successfully to the market (English only) 2014-05-19  
Presentation - Challenges during the development of advanced-therapy medicinal products (Paula Salmikangas) (English only) 2014-10-21  
Presentation - Procedures and support to developers (Patrick Celis) (English only) 2014-10-21  
Presentation - Classification of advanced-therapy medicinal products (Egbert Flory) (English only) 2014-10-21  
Presentation - Autologous cell therapies manufactured in the hospital: Advanced-therapy medicinal products or not? (Kenneth K. Kleinhenz) (English only) 2014-10-21  
Presentation - CAT’s views on classification of advanced-therapy medicinal products (Nicolas Ferry) (English only) 2014-10-21  
Presentation - Cell-based therapies for cardiac repair (Martina Schüßler-Lenz) (English only) 2014-10-21  
Presentation - Quality aspects for cell-based products for cardiac repair (Paula Salmikangas) (English only) 2014-10-21  
Presentation - Stem cell therapy for myocardial repair (Birgit Assmus) (English only) 2014-10-21  
Presentation - Cell-based therapies for cardiac repair (Claire Beuneu) (English only) 2014-10-21  
Presentation - Clinical aspects for cell-based therapies for cardiac repair (Pieter A. Doevendans) (English only) 2014-10-21  

Media Videos


Related information